INTRODUCTION {#s1}
============

Hypopharyngeal squamous cell carcinoma (HSCC), which originates from the mucosa of the hypopharynx, has one of the poorest prognoses among head and neck cancers \[[@R1]\]. Currently, the standard treatment strategy for HSCC is surgery followed by radiotherapy \[[@R1]\]. Significant advances in radiotherapeutic strategies for HSCC, such as intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and helical tomotherapy (TOMO), have been made in recent years \[[@R1], [@R2]\]. However, local recurrence and distant metastases after radiotherapy due to tumor radioresistance remain a serious obstacle to successful treatment of HSCC, and the 5-year survival rate remains at approximately 25% to 40% \[[@R3]\]. Although mechanisms of radioresistance have been extensively studied \[[@R4], [@R5]\], the underlying molecular pathways and targets involved in HSCC radioresistance are not fully understood. Currently, there are few strategies available for overcoming this clinical problem.

In the past decade, advances in genome-wide analysis of gene expression have revealed that the majority of genes in the genome are transcribed into non-coding RNAs (ncRNAs) \[[@R6]\]. Long non-coding RNAs (lncRNAs) are ncRNAs longer than 200 nucleotides \[[@R7]\], and they have important roles in chromatin modification and transcriptional and post-transcriptional processing \[[@R8], [@R9]\]. Specifically, lncRNAs have been demonstrated to promote the development, invasion, and metastasis of many tumors by a variety of mechanisms \[[@R10], [@R11]\]. Notably, several studies have shown that lncRNAs are extremely important for controlling cancer radioresistance \[[@R12]--[@R15]\], but the roles of lncRNAs in HSCC radioresistance are still unknown.

Accumulating evidence demonstrates that lncRNAs are widely involved in the regulation of proliferation, DNA damage response, apoptosis, and the cell cycle in cancer cells \[[@R16]--[@R22]\], all of which are closely associated with the development of radioresistance \[[@R23]\]. Moreover, the roles of several lncRNAs, such as MALAT1 \[[@R13], [@R24]\], TUG1 \[[@R14]\], NEAT1 \[[@R25]\], and BOKAS \[[@R26]\], in radioresistance have been identified, although their detailed mechanisms remain largely unclear. Radioresistance is the leading cause of recurrence and poor prognosis in HSCC patients. Hence, it is of vital significance to figure out whether or not lncRNAs can become biomarkers for radioresistant HSCC and explore the molecular mechanisms underlying HSCC radioresistance.

It is very unlikely that a single molecule or gene is responsible for radioresistance in HSCC; therefore, to provide useful information for elucidating the molecular mechanisms that lncRNAs and mRNAs are involved in HSCC radioresistance, we used microarray techniques to perform large-scale analyses of lncRNA and mRNA expressions to comprehensively search for mechanisms of HSCC radioresistance. We initially generated a radioresistant HSCC subclone (RS-FaDu) from the parental FaDu cell line via long-term fractionated irradiation. Subsequently, we investigated differences in time-course lncRNA and mRNA expression profiles between RS-FaDu and parent FaDu cells after radiation therapy by microarray and bioinformatics analyses.

RESULTS {#s2}
=======

Establishment and validation of radioresistant HSCC subclone cell line {#s2_1}
----------------------------------------------------------------------

Radioresistance was measured by clonogenic survival assay following exposure to a range of radiation doses (0--6 Gy). As shown in Figure [1A](#F1){ref-type="fig"}, RS-FaDu and FaDu cells showed no difference in clonogenic formation ability when the radiation dose was 0 Gy. However, the RS-FaDu cells had significantly more and larger surviving colonies than did the control FaDu cells when the radiation dose was 4 Gy or 6 Gy. Clonogenic survival curves showed the surviving colony numbers of FaDu cells were significantly lower than those of RS-FaDu cells (\*\**P* \< 0.01, both) at 4 Gy and 6 Gy (Figure [1B](#F1){ref-type="fig"}).

![Radioresistance measurement by clonogenic survival assay and apoptosis assay\
(**A**) RS-FaDu and parental FaDu cells irradiated with different radiation doses (0, 2, 4, and 6 Gy) and the crystal violet-stained colonies were photographed at 12 days after irradiation. (**B**) Colonies containing more than 50 cells for survival colonies and scoring. (**C**) RS-FaDu and FaDu cells irradiated with 4 Gy. The apoptosis detection by FCM Annexin V/PI staining. The proportions of Annexin V+/PI− and Annexin V+/PI+ cells for early- and late-stage apoptosis. (**D**) At 0 h after irradiation with 4 Gy, there was no difference between RS-FaDu and FaDu in their fractions of apoptosis cells. At 24 h, 48 h, or 72 h after irradiation, the fraction of apoptosis cells in RS-FaDu cells was lower than that in FaDu cells. All experiments were performed in triplicate wells; points, mean; bars, SD. \*\**P* \< 0.01.](oncotarget-08-40994-g001){#F1}

To further verify the radioresistant phenotype of RS-FaDu, RS-FaDu and FaDu cells were also examined by apoptosis assays. RS-FaDu and FaDu cells were treated with 4 Gy. Their fractions of apoptosis cells did not differ at 0 h, but at 24, 48, or 72 h after irradiation, the fractions of apoptotic RS-FaDu cells were much lower than those of FaDu cells (\*\**P* \< 0.01, Figure [1C](#F1){ref-type="fig"}, [1D](#F1){ref-type="fig"}). These results indicated that RS-FaDu cells were much more radioresistant than their parent FaDu cells. These data indicated that the RS-FaDu subclone cell line was successfully established.

LncRNA and mRNA profiles {#s2_2}
------------------------

Hierarchical clustering is an unsupervised classification method that can separate multiple groups without the use of the group information. In microarray data analysis, cluster analysis grouped samples together based on expression intensity revealed differences between clustering group and true group results for removal of outlier samples. The dendrogram showed the relationships among lncRNA (Figure [2A](#F2){ref-type="fig"}) and mRNA (Figure [2B](#F2){ref-type="fig"}) expression patterns between RS-FaDu cells and FaDu cells at 0, 2, and 48 h, respectively, after 4 Gy radiation exposure.

![LncRNA (**A**) and mRNA (**B**) expression profiling by human lncRNA microarray. The sample tree on the top of the figure shows sample group information, which reflects relationships among samples. In the dendrogram, red indicates high relative expression, and blue indicates low relative expression. M, E, and F refer to 0 hr, 2 hrs, and 48 hrs after exposure to 4 Gy irradiation, respectively. The Arabic numerals presented the experiment repeats.](oncotarget-08-40994-g002){#F2}

A scatter plot is a visualization method to show the differentially expressed lncRNAs (Figure [3](#F3){ref-type="fig"}, A1--C1) and mRNAs (Figure [3](#F3){ref-type="fig"}, D1--F1). The values plotted on the X and Y axes were the averaged normalized signal values of groups of samples (log2 scaled). The X-axis represents the control group (FaDu), while the Y-axis represents the case group (RS-FaDu). All lncRNAs/mRNAs that were not differentially expressed were around the line Y = X and labelled black. Points that were above and apart from Y = X were upregulated lncRNAs/mRNAs and labelled red, and points that were below and apart from Y = X were downregulated lncRNAs/mRNAs and labelled green, respectively. A volcano plot is another visualization method to show differences in lncRNA (Figure [3](#F3){ref-type="fig"}, A2--C2) and mRNA (Figure [3](#F3){ref-type="fig"}, D2--F2) expression between the case group (RS-FaDu) and the control group (FaDu). The X-axis in the volcano plot represents FC (after log2 transformation) and the Y-axis represents *P*-value (after log transformation). The lncRNAs/mRNAs on the top left were downregulated lncRNAs/mRNAs (FC ≥ 2.0, *P* value \< 0.05). The lncRNAs/mRNAs on the top right were upregulated lncRNAs/mRNAs (FC ≥ 2.0, *P* value \< 0.05). Upregulated lncRNAs/mRNAs and downregulated lncRNAs/mRNAs were labelled red and green, respectively. After the RS-FaDu and FaDu cells were treated with 4 Gy of irradiation, their lncRNA expression levels differed significantly in 575, 361, and 1714 lncRNAs (data not shown) at 0, 2, and 48 h, respectively. Of those, 302 were upregulated and 273 were downregulated at 0 h; 113 were upregulated and 248 were downregulated at 2 h; and 759 were upregulated and 955 were downregulated at 48 h, respectively. In addition, we identified 1249, 781, and 2521 (data not shown) mRNAs that were significantly differentially expressed at 0, 2, and 48 h, respectively. Of those, 387 were upregulated and 862 were downregulated at 0 h; 227 were upregulated and 554 were downregulated at 2 h; and 1089 were upregulated and 1432 were downregulated at 48 h. Volcano plot filtering was also used to identify the 10 most upregulated and downregulated lncRNAs (Table [1](#T1){ref-type="table"}) and mRNAs (Table [2](#T2){ref-type="table"}) in RS-FaDu cells at 0, 2, and 48 h after 4 Gy radiation, respectively.

![Differences in lncRNA and mRNA expression profiles between RS-FaDu cells and parental FaDu cells\
(**A1**--**F1**) Scatter plots. Scatter plot showed the differentially expressed lncRNAs (A1--C1) and mRNAs (D1--F1). The values on the X and Y axes from the averaged normalized signal values of groups of samples (log2 scaled). X-axis for control group (FaDu), and Y-axis for case group (RS-FaDu). All the lncRNAs/mRNAs without differential expression around the line Y = X in black. Points above Y = X and apart from Y = X are upregulated lncRNAs/mRNAs in red, and points below Y = X and apart from Y = X are downregulated lncRNAs/mRNAs in green, respectively. The threshold for differentially expressed genes was set at FC ≥ 2.0. (**A2**--**F2**) Volcano plots for the differences in lncRNA (A2--C2) and mRNA (D2--F2) expression between the case group (RS-FaDu) and control group (FaDu). The X-axis in the volcano plot represents FC (after log2 transformation) and the Y-axis in the plot represents *P*-value (after log transformation). The lncRNAs/mRNAs on the top left show downregulated lncRNAs/mRNAs (FC ≥ 2.0, *P* \< 0.05). The lncRNAs/mRNAs on the top right show upregulated lncRNAs/mRNAs (FC ≥ 2.0, *P* \< 0.05). Upregulated lncRNAs/mRNAs and downregulated lncRNAs/mRNAs are shown in red and green, respectively. MS vs. M, 0 h; ES vs. E, 2 h; FS vs. F, 48 h.](oncotarget-08-40994-g003){#F3}

###### Ten most upregulated and downregulated lncRNAs in RS-FaDu cells at 0, 2, and 48 h after 4 Gy radiation

  Probe name   FC (abs)   Regulation   lncRNA ID           Chr   Strand   Gene                Class        Time
  ------------ ---------- ------------ ------------------- ----- -------- ------------------- ------------ ------
  p7538        6.58       up           ENST00000587434.1   17    \+       ENSG00000267601.1   Antisense    0 h
  p28462       5.94       up           ASO3704                            ASO3704             Intergenic   0 h
  p8064        4.75       up           ENST00000563172.1   18    \+       ENSG00000261780.2   Intergenic   0 h
  p19771       4.63       up           TCONS_00023442      15    \+       XLOC_011287         Intergenic   0 h
  p37817_v4    4.62       up           ENST00000607175.1   6     −        ENSG00000272468.1                0 h
  p35075_v4    4.54       up           ENST00000594101.1   3     \+       ENSG00000242086.3   Intergenic   0 h
  p35072_v4    4.51       up           ENST00000597871.1   3     \+       ENSG00000242086.3   Intergenic   0 h
  p11909       4.41       up           ENST00000519700.1   3     \+       ENSG00000242770.2   Intergenic   0 h
  p6707        4.38       up           ENST00000578710.1   17    −        ENSG00000264673.1   Intergenic   0 h
  p35069_v4    4.30       up           ENST00000438608.1   3     \+       ENSG00000242086.3   Intergenic   0 h
  p33918       19.81      down         hox-HOXD10-35       2     \+       hox-HOXD10-35       Intronic     0 h
  p33919       17.23      down         hox-HOXD10-36       2     \+       hox-HOXD10-36       Intronic     0 h
  p28077       14.53      down         nc-HOXD10-9         2     \+       nc-HOXD10-9         Intronic     0 h
  p5033        13.80      down         ENST00000556653.1   14    \+       ENSG00000258914.1   Intergenic   0 h
  p28072       12.49      down         nc-HOXD10-13        2     \+       nc-HOXD10-13        Intronic     0 h
  p10912       12.20      down         ENST00000430181.1   21    \+       ENSG00000235890.1   Intronic     0 h
  p28071       11.64      down         nc-HOXD10-12        2     \+       nc-HOXD10-12        Intronic     0 h
  p6908        10.93      down         ENST00000433510.1   17    −        ENSG00000233283.2   Intergenic   0 h
  p8814        9.47       down         ENST00000601506.1   19    \+       ENSG00000269495.1   Antisense    0 h
  p33495       8.82       down         ENST00000589927.1   19    \+       ENSG00000186526.7   Antisense    0 h
  p29588       13.61      up           TCONS_00018436      10    −        XLOC_008730         Intergenic   2 h
  p29587       12.47      up           TCONS_00017927      10    −        XLOC_008730         Intergenic   2 h
  p22664       7.26       up           TCONS_00010875      5     −        XLOC_004700         Intergenic   2 h
  p5789        6.87       up           ENST00000567091.1   16    −        ENSG00000260394.2   Divergent    2 h
  p3381        6.81       up           ENST00000547963.1   12    −        ENSG00000249550.2   Intergenic   2 h
  p3379        5.93       up           ENST00000550905.1   12    −        ENSG00000249550.2   Intergenic   2 h
  p5993        5.64       up           ENST00000567668.1   16    −        ENSG00000260609.1   Intergenic   2 h
  p19771       5.11       up           TCONS_00023442      15    \+       XLOC_011287         Intergenic   2 h
  p737         5.03       up           ENST00000453572.1   1     −        ENSG00000232184.1   Intronic     2 h
  p22663       5.01       up           TCONS_00010233      5     −        XLOC_004700         Intergenic   2 h
  p8814        23.31      down         ENST00000601506.1   19    \+       ENSG00000269495.1   Antisense    2 h
  p8817        15.69      down         ENST00000596286.1   19    \+       ENSG00000268739.1   Antisense    2 h
  p28076       12.71      down         nc-HOXD10-8         2     \+       nc-HOXD10-8         Antisense    2 h
  p33919       12.04      down         hox-HOXD10-36       2     \+       hox-HOXD10-36       Intronic     2 h
  p33918       11.42      down         hox-HOXD10-35       2     \+       hox-HOXD10-35       Intronic     2 h
  p28072       10.30      down         nc-HOXD10-13        2     \+       nc-HOXD10-13        Intronic     2 h
  p33495       10.15      down         ENST00000589927.1   19    \+       ENSG00000186526.7   Antisense    2 h
  p28071       10.01      down         nc-HOXD10-12        2     \+       nc-HOXD10-12        Intronic     2 h
  p8609        8.80       down         ENST00000595892.1   19    \+       ENSG00000269640.1   Divergent    2 h
  p28077       8.48       down         nc-HOXD10-9         2     \+       nc-HOXD10-9         Intronic     2 h
  p40301_v4    21.79      up           XR_427456.1         3     \+                                        48 h
  p3438        14.16      up           ENST00000545853.1   12    −        ENSG00000256732.1   Intergenic   48 h
  p18725       13.84      up           TCONS_00020973      12    −        XLOC_010243         Intergenic   48 h
  p33351       12.63      up           ENST00000420462.1   1     −        ENSG00000242663.1   Antisense    48 h
  p11893       12.18      up           ENST00000462011.1   3     \+       ENSG00000244464.1   Intergenic   48 h
  p37817_v4    11.39      up           ENST00000607175.1   6     −        ENSG00000272468.1                48 h
  p26490       11.25      up           uc004aej.3          9     −        BC065763            Intergenic   48 h
  p26072       10.39      up           uc002oet.3          19    \+       BC024306            Intergenic   48 h
  p29587       10.28      up           TCONS_00017927      10    −        XLOC_008730         Intergenic   48 h
  p14418       10.03      up           ENST00000584911.1   6     −        ENSG00000223414.2   Intergenic   48 h
  p28077       88.86      down         nc-HOXD10-9         2     \+       nc-HOXD10-9         Intronic     48 h
  p33919       69.03      down         hox-HOXD10-36       2     \+       hox-HOXD10-36       Intronic     48 h
  p8814        52.88      down         ENST00000601506.1   19    \+       ENSG00000269495.1   Antisense    48 h
  p28072       49.57      down         nc-HOXD10-13        2     \+       nc-HOXD10-13        Intronic     48 h
  p28076       45.45      down         nc-HOXD10-8         2     \+       nc-HOXD10-8         Antisense    48 h
  p28071       41.28      down         nc-HOXD10-12        2     \+       nc-HOXD10-12        Intronic     48 h
  p33495       38.99      down         ENST00000589927.1   19    \+       ENSG00000186526.7   Antisense    48 h
  p33920       33.10      down         hox-HOXD11-34       2     \+       hox-HOXD11-34       Intronic     48 h
  p25262       26.48      down         XR_108533.1         3     −        LOC100505902        Intergenic   48 h
  p33918       23.62      down         hox-HOXD10-35       2     \+       hox-HOXD10-35       Intronic     48 h

###### Ten most upregulated and downregulated mRNAs in RS-FaDu cells at 0, 2 and 48 h after 4 Gy radiation

  Probe name      FC (abs)    Regulation   Genbank accession   Gene symbol   Time
  --------------- ----------- ------------ ------------------- ------------- ------
  A_21_P0005630   23.64873    up           NR_121672           LINC00824     0 h
  A_33_P3258346   9.20869     up           NM_017523           XAF1          0 h
  A_33_P3384287   9.20060     up           NM_002579           PALM          0 h
  A_33_P3238533   8.80111     up           NM_001105528        CCDC178       0 h
  A_23_P87013     7.73073     up           NM_001001522        TAGLN         0 h
  A_33_P3381948   7.55051     up           NM_001080436        WTIP          0 h
  A_23_P1029      7.11102     up           NM_017459           MFAP2         0 h
  A_33_P3640690   6.67747     up           NM_001128128        ZEB1          0 h
  A_24_P557479    6.51224     up           NM_017523           XAF1          0 h
  A_33_P3237552   6.43079     up           NM_032843           FIBCD1        0 h
  A_33_P3290780   52.36956    down         NM_001185156        IL24          0 h
  A_33_P3260654   26.23980    down         EU030678                          0 h
  A_24_P684183    18.09698    down         NM_025257           SLC44A4       0 h
  A_23_P304897    15.30950    down         NM_000623           BDKRB2        0 h
  A_23_P128744    13.02192    down         NM_000710           BDKRB1        0 h
  A_23_P122937    12.17637    down         NM_014800           ELMO1         0 h
  A_21_P0009192   11.46747    down                                           0 h
  A_23_P65189     11.36208    down         NM_000209           PDX1          0 h
  A_23_P39315     10.78665    down         NM_021187           CYP4F11       0 h
  A_23_P404494    10.34955    down         NM_002185           IL7R          0 h
  A_21_P0005630   73.61931    up           NR_121672           LINC00824     2 h
  A_33_P3238533   61.95869    up           NM_001105528        CCDC178       2 h
  A_23_P69030     11.65424    up           NM_001850           COL8A1        2 h
  A_33_P3245439   9.52713     up           NM_001250           CD40          2 h
  A_23_P209055    8.46069     up           NM_001771           CD22          2 h
  A_33_P3293675   7.34682     up           NM_006598           SLC12A7       2 h
  A_24_P917886    7.22717     up           XM_006709947        MUC5AC        2 h
  A_33_P3382177   7.02720     up           NM_003255           TIMP2         2 h
  A_32_P530933    6.34961     up           NM_015617           PYGO1         2 h
  A_23_P159721    6.29696     up           NM_004224           GPR50         2 h
  A_33_P3393971   27.56643    down         NM_000299           PKP1          2 h
  A_23_P23296     24.91828    down         NM_000299           PKP1          2 h
  A_23_P143029    21.06592    down         NM_021192           HOXD11        2 h
  A_24_P245379    13.24701    down         NM_002575           SERPINB2      2 h
  A_33_P3220911   12.74436    down         NM_004335           BST2          2 h
  A_33_P3226810   12.12693    down         NM_003810           TNFSF10       2 h
  A_23_P404494    10.63455    down         NM_002185           IL7R          2 h
  A_24_P236935    10.10874    down         NM_001012964        KLK6          2 h
  A_21_P0011633   9.24221     down         NM_000526           KRT14         2 h
  A_23_P39315     9.24213     down         NM_021187           CYP4F11       2 h
  A_33_P3238533   132.03939   up           NM_001105528        CCDC178       48 h
  A_21_P0005630   41.69042    up           NR_121672           LINC00824     48 h
  A_23_P161190    30.52496    up           NM_003380           VIM           48 h
  A_23_P70468     29.94054    up           NM_012367           OR2B6         48 h
  A_33_P3340014   18.30612    up           NM_016157           TRO           48 h
  A_33_P3514487   16.05847    up           NM_198481           VSTM1         48 h
  A_24_P211849    13.71514    up           NM_001166220        TBX20         48 h
  A_23_P421379    12.63051    up           NM_000612           IGF2          48 h
  A_23_P69030     12.08606    up           NM_001850           COL8A1        48 h
  A_23_P41804     11.93085    up           NM_033120           NKD2          48 h
  A_23_P39315     39.50620    down         NM_021187           CYP4F11       48 h
  A_23_P143029    38.05859    down         NM_021192           HOXD11        48 h
  A_23_P50710     31.23669    down         NM_001082           CYP4F2        48 h
  A_33_P3393971   26.30644    down         NM_000299           PKP1          48 h
  A_23_P23296     24.31587    down         NM_000299           PKP1          48 h
  A_24_P42693     23.02732    down         NM_021187           CYP4F11       48 h
  A_23_P108280    20.67472    down         NM_023944           CYP4F12       48 h
  A_24_P684183    19.34901    down         NM_025257           SLC44A4       48 h
  A_23_P138541    14.88679    down         NM_003739           AKR1C3        48 h
  A_23_P300781    13.48931    down         NM_013316           CNOT4         48 h

Venn diagrams of the numbers and percentages of differentially expressed genes are shown in Figure [4](#F4){ref-type="fig"}. The results showed that there were 20 (2.0%) common differentially upregulated lncRNAs (Figure [4A](#F4){ref-type="fig"}) and 65 (5.4%) common differentially downregulated lncRNAs (Figure [4B](#F4){ref-type="fig"}) for the three groups ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}). In addition, the numbers of common upregulated (Figure [4C](#F4){ref-type="fig"}) and downregulated (Figure [4D](#F4){ref-type="fig"}) differentially expressed mRNAs were 59 (4.3%) and 153 (7.0%), respectively ([Supplementary Table 2](#SD3){ref-type="supplementary-material"}).

![Venn diagram for the common and exclusively expressed lncRNAs and mRNAs from each group\
FaDu and RS-FaDu cells at 0, 2, and 48 h after irradiation with 4 Gy. Different lncRNAs and mRNAs between FaDu and RS-FaDu as determined by microarray analysis for overlapping signature. (**A**) The overlapping results of upregulated differentially expressed lncRNAs. (**B**) The overlapping results of downregulated differentially expressed lncRNAs. (**C**) The overlapping results of upregulated differentially expressed mRNAs. (**D**) The overlapping results of downregulated differentially expressed mRNAs. MS vs. M, 0 h; ES vs. E, 2 h; FS vs. F, 48 h.](oncotarget-08-40994-g004){#F4}

Validation of differential lncRNA expression by qRT-PCR {#s2_3}
-------------------------------------------------------

The qRT-PCR was used to confirm the reliability and validity of microarray data. We selected four lncRNAs (ENST00000470135, TCONS_00010875, TCONS_00018436, and hox-HOXD10-35) for validation since these lncRNAs had consistent up- or downregulations at the three time points and their FC values were prominent at some time points. Additionally, four mRNAs (CKMT1A, GPNMB, FBLN5, and GDA) were validated as well due likely to their potential roles in irradiation response or radioresistance. The relative expression levels of the target RNAs were given as ratios of β-actin transcript levels in the same RNA samples. As shown in Figure [5](#F5){ref-type="fig"}, the expression levels of these eight genes were consistent with the microarray results, indicating the reliability of the microarray data and correlation of these genes with radioresistance.

![Validation of differential lncRNA expressions by qRT-PCR\
(**A**) ENST00000470135; (**B**) hox-HOXD10-35; (**C**) TCONS_00010875; (**D**) TCONS_00018436; (**E**) CKMT1A; (**F**) GPNMB; (**G**) FBLN5; (**H**) GDA. After normalization to ACTB, data were presented as mean ± SD. *n* = 3, \**P* \< 0.05, \*\**P* \< 0.01.](oncotarget-08-40994-g005){#F5}

Potential roles of TCONS_00018436 in regulation of radioresistance of HSCC {#s2_4}
--------------------------------------------------------------------------

We then assessed the expression of the four validated lncRNAs in primary tumor tissues of HSCC patients *versus* their recurrent ones after postoperative radiotherapy, using qRT-PCR. The expression of the three lncRNAs showed no remarkable difference between two groups of samples (Figure [6A--6C](#F6){ref-type="fig"}), while the significant upregulation of TCONS_00018436 in relapsed tumor samples was found (Figure [6D](#F6){ref-type="fig"}, \**P* \< 0.05). Further, after we stably knocked down TCONS_00018436 in FaDu-RS cells using lentiviral transfection, both transfected FaDu-RS cells (FaDu-RS-sh) and FaDu-RS cells were treated with 4 Gy, 6 Gy and 8 Gy irradiation, respectively. The apoptotic cells at 48 h after irradiation were determined by Annexin V-FITC/PI and flow cytometry. As shown in Figure [6E](#F6){ref-type="fig"}, depletion of TCONS_00018436 significantly sensitized RS-FaDu cells to the indicated doses of radiation (\**P* \< 0.05), indicating that upregulated TCONS_00018436 might control radioresistance of HSCC cells during exposure to radiation. However, the underlying mechanism remains to be further investigated.

![Potential roles of TCONS_00018436 in radioresistance of HSCC cells\
The relative expression of ENST00000470135 (**A**), hox-HOXD10-35 (**B**), TCONS_00010875 (**C**) and TCONS_00018436 (**D**) in primary *vs*. recurrent HSCC tissue samples were measured by qRT-PCR. Their expression in each sample was normalized to the mean expression of their respective primary samples. Data were presented as mean ± SD. *n* = 13, \**P* \< 0.05. (**E**) FaDu-RS cells and those stably transfected with shRNA of TCONS_00018436 were both treated with 4 Gy, 6 Gy, and 8 Gy irradiation, respectively. The fractions of apoptotic cells were determined by using Annexin V/PI dual staining after 48 h. Data were presented as mean ± SD. *n* = 3, \**P* \< 0.05.](oncotarget-08-40994-g006){#F6}

Bioinformatics analyses {#s2_5}
-----------------------

In order to identify potential protein regulators involved in radioresistance of HSCC, we performed pathway enrichment analysis by functionally annotating and differentially expressed mRNAs in FaDu *vs*. FaDu-RS cells at 0, 2, and 48 h after irradiation. The detailed information on significantly enriched pathway terms and dysregulated mRNAs at the three time points involved in them was presented in [Supplementary Tables 3](#SD4){ref-type="supplementary-material"}, [4](#SD5){ref-type="supplementary-material"}, [5](#SD6){ref-type="supplementary-material"}, respectively. The most significant 30 terms sorted by corrected *P*-value were separately listed in three histograms, according to the time points after irradiation shown in [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}. This analysis approach may help identify altered expression of mRNAs involved in pathways associated with radioresistance, whose dysregulation might have an impact on sensitivity of HSCC to radiation.

An increasing number of lncRNAs have been shown to regulate expression of target genes in *cis* or in *trans*. Thus, we found significant correlations between dysregulated lncRNAs and mRNAs at 0, 2, and 48 h after irradiation, respectively. After lncRNA and mRNA correlation, *cis*-prediction and *trans*-prediction were both applied to the data. The final lncRNA prediction results are the combination of results from these two prediction parts at 0, 2, and 48 h as shown in Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, respectively. These pathway enrichment analysis may provide some mRNA candidates that are potentially associated with radioresistance. Furthermore, we might further identify the lncRNAs in regulating the expressions of nearby or distant genes which encode these mRNAs based on the prediction results.

###### lncRNA target prediction of RS-FaDu vs. FaDu at 0 h

  lncRNA      mRNA             Correlation    *P*-value     Direction (lncRNA-mRNA)   cisregulation   transregulation
  ----------- ---------------- -------------- ------------- ------------------------- --------------- ---------------------
  p3758       A_33_P3421178    0.999026552    0.000001421   down-down                 Sense           
  p13056      A_21_P0012973    0.993822774    0.000057119   up-up                     Sense           
  p25219      A_33_P3368495    0.998540055    0.000003196   down-down                                 miRNA sequestration
  p7538       A_33_P3382177    0.999529708    0.000000332   up-up                     Antisense       
  p35072_v4   A_19_P00315941   0.997663892    0.000008180   up-up                     Sense           
  p12195      A_19_P00316857   0.994153893    0.000051166   up-up                     Sense           
  p26166      A_24_P557479     −0.997108515   0.000012529   down-up                                   miRNA sequestration
  p29619      A_21_P0007233    0.992506995    0.000084007   down-down                 Sense           
  p38695_v4   A_23_P148919     −0.99696864    0.000013770   up-down                                   miRNA sequestration
  p192        A_23_P148919     0.994529457    0.000044808   down-down                 Antisense       
  p1665       A_33_P3278211    0.994573678    0.000044088   down-down                 Sense           
  p30074      A_33_P3289416    0.990995817    0.000121248   down-down                                 miRNA sequestration
  p10587      A_24_P115199     −0.99188824    0.000098434   up-down                                   miRNA sequestration
  p8323       A_24_P115199     −0.997557313   0.000008943   up-down                                   miRNA sequestration
  p687        A_21_P0001239    0.991689858    0.000103301   down-down                 Sense           
  p686        A_21_P0001239    0.999058836    0.000001328   down-down                 Sense           
  p34021_v4   A_21_P0001239    0.998331716    0.000004172   down-down                 Sense           
  p7388       A_33_P3341836    0.997644418    0.000008317   up-up                                     miRNA sequestration
  p687        A_32_P212373     0.991025177    0.000120460   down-down                 Sense           
  p686        A_32_P212373     0.998954092    0.000001640   down-down                 Sense           
  p34021_v4   A_32_P212373     0.998577934    0.000003032   down-down                 Sense           
  p686        A_21_P0001238    0.994752897    0.000041226   down-down                 Sense           
  p34021_v4   A_21_P0001238    0.992305807    0.000088573   down-down                 Sense           
  p38695_v4   A_33_P3414487    −0.99790579    0.000006574   up-down                                   miRNA sequestration
  p10433      A_23_P210425     0.993170163    0.000069811   up-up                     Antisense       
  p4963       A_23_P304897     0.994892042    0.000039070   down-down                 Intronic        
  p6222       A_24_P80135      0.997657113    0.000008227   down-down                                 miRNA sequestration
  p15211      A_23_P320878     0.993544033    0.000062385   down-down                                 miRNA sequestration

###### LncRNA target prediction of RS-FaDu vs. FaDu at 2 h

  lncRNA      mRNA            Correlation    *P*-value     Direction (lncRNA-mRNA)   cisregulation       transregulation
  ----------- --------------- -------------- ------------- ------------------------- ------------------- ---------------------
  p20305      A_33_P3266898   −0.996352571   0.000019931   up-down                                       miRNA sequestration
  p30194      A_33_P3266898   −0.996726605   0.000016055   up-down                                       miRNA sequestration
  p33576      A_32_P131031    0.992702048    0.000079696   down-down                 Intergenic (10 k)   
  p36121_v4   A_21_P0004245   0.990861638    0.000124883   down-down                 Sense               
  p8814       A_24_P236935    0.995770285    0.000026798   down-down                 Antisense           
  p687        A_24_P915692    0.990515655    0.000134503   down-down                                     miRNA sequestration
  p24838      A_33_P3278211   0.998051663    0.000005690   down-down                 Sense               
  p1665       A_33_P3278211   0.998814061    0.000002109   down-down                 Sense               
  p37870_v4   A_33_P3289416   −0.990915820   0.000123409   up-down                                       miRNA sequestration
  p25347      A_24_P940149    −0.996508538   0.000018264   up-down                                       miRNA sequestration
  p25347      A_32_P152437    0.996042331    0.000023464   up-up                                         miRNA sequestration
  p30340      A_24_P602871    0.995141025    0.000035357   down-down                                     miRNA sequestration
  p25605      A_23_P329112    0.996929698    0.000014126   up-down                                       miRNA sequestration
  p25347      A_23_P329112    0.994658656    0.000042719   up-down                                       miRNA sequestration
  p11034      A_24_P66027     0.991916997    0.000097738   down-down                 Antisense           
  p28133      A_24_P115199    0.997640377    0.000008345   down-down                                     miRNA sequestration
  p30155      A_24_P115199    0.990576762    0.000132778   down-down                                     miRNA sequestration
  p33798      A_23_P60339     −0.994723656   0.000041686   up-down                                       miRNA sequestration
  p687        A_32_P212373    0.992913328    0.000075153   down-down                 Sense               
  p686        A_32_P212373    0.994692846    0.000042174   down-down                 Sense               
  p34021_v4   A_32_P212373    0.991057378    0.000119598   down-down                 Sense               
  p20305      A_23_P208389    0.996581866    0.000017505   up-up                                         miRNA sequestration
  p34907_v4   A_33_P3333554   0.990605549    0.000131969   down-down                                     miRNA sequestration
  p10433      A_23_P210425    0.998311004    0.000004277   up-up                     Antisense           
  p30335      A_23_P157022    0.991277419    0.000113793   down-down                                     miRNA sequestration
  p15938      A_21_P0005906   0.995291866    0.000033198   down-down                 Intergenic (10 k)   
  p34907_v4   A_33_P3378430   0.991616881    0.000105120   down-down                                     miRNA sequestration
  p20305      A_32_P31618     −0.992612720   0.000081656   up-down                                       miRNA sequestration
  p15519      A_33_P3233273   0.990760089    0.000127670   down-down                 Intergenic (10 k)   

###### LncRNA target prediction of RS-FaDu vs. FaDu at 48 h

  lncRNA      mRNA             Correlation    *P*-value     Direction (lncRNA-mRNA)   cisregulation       transregulation
  ----------- ---------------- -------------- ------------- ------------------------- ------------------- ---------------------
  p24892      A_33_P3250133    0.993774158    0.000058021   up-up                                         miRNA sequestration
  p36462_v4   A_24_P111242     −0.997243502   0.000011387   down-up                                       miRNA sequestration
  p2627       A_21_P0014268    0.996216336    0.000021447   up-up                     Sense               
  p25293      A_23_P38813      −0.997569809   0.000008852   up-down                                       miRNA sequestration
  p24618      A_23_P38813      0.996136217    0.000022364   down-down                                     miRNA sequestration
  p37916_v4   A_23_P38813      −0.991608950   0.000105319   up-down                                       miRNA sequestration
  p44617_v4   A_23_P38813      −0.993806999   0.000057411   up-down                                       miRNA sequestration
  p25051      A_23_P38813      −0.995045168   0.000036765   up-down                                       miRNA sequestration
  p28498      A_23_P38813      −0.994453852   0.000046054   up-down                                       miRNA sequestration
  p122        A_23_P38813      −0.994491445   0.000045433   up-down                                       miRNA sequestration
  p3143       A_23_P38813      0.997519222    0.000009224   down-down                                     miRNA sequestration
  p11437      A_23_P38813      −0.995453161   0.000030964   up-down                                       miRNA sequestration
  p37026_v4   A_23_P38813      −0.994529667   0.000044805   up-down                                       miRNA sequestration
  p23798      A_23_P38813      0.992085159    0.000093719   down-down                                     miRNA sequestration
  p29606      A_23_P38813      −0.998223527   0.000004731   up-down                                       miRNA sequestration
  p28658      A_23_P38813      −0.993772836   0.000058046   up-down                                       miRNA sequestration
  p24771      A_21_P0014060    0.995431495    0.000031259   up-up                     Sense               
  p34907_v4   A_24_P319364     −0.996770625   0.000015626   down-up                                       miRNA sequestration
  p29827      A_33_P3336622    0.994560238    0.000044306   up-up                                         miRNA sequestration
  p29606      A_33_P3336622    0.993785701    0.000057806   up-up                                         miRNA sequestration
  p26063      A_33_P3390723    0.990423713    0.000137119   up-up                                         miRNA sequestration
  p24892      A_23_P45799      −0.997314248   0.000010810   up-down                                       miRNA sequestration
  p34907_v4   A_24_P129232     −0.992791851   0.000077749   down-up                                       miRNA sequestration
  p18271      A_24_P684183     −0.990582868   0.000132606   up-down                                       miRNA sequestration
  p44617_v4   A_24_P684183     −0.990879668   0.000124391   up-down                                       miRNA sequestration
  p18272      A_24_P684183     −0.993001983   0.000073287   up-down                                       miRNA sequestration
  p8313       A_23_P165186     0.990188970    0.000143912   up-up                     Bidirectional       
  p7538       A_33_P3382177    0.990676885    0.000129976   up-up                     Antisense           
  p41822_v4   A_32_P126698     0.993882119    0.000056028   up-up                                         miRNA sequestration
  p25293      A_23_P149099     −0.991073247   0.000119175   up-down                                       miRNA sequestration
  p18271      A_23_P149099     −0.991096396   0.000118558   up-down                                       miRNA sequestration
  p823        A_23_P149099     −0.992591892   0.000082117   up-down                                       miRNA sequestration
  p23798      A_23_P149099     0.993960353    0.000054606   down-down                                     miRNA sequestration
  p25999      A_23_P149099     −0.991209023   0.000115582   up-down                                       miRNA sequestration
  p25051      A_24_P382630     −0.998198512   0.000004865   up-down                                       miRNA sequestration
  p28498      A_24_P382630     −0.991372680   0.000111325   up-down                                       miRNA sequestration
  p16320      A_23_P62679      −0.995317469   0.000032838   up-down                                       miRNA sequestration
  p13683      A_33_P3233841    0.993630385    0.000060729   up-up                     Antisense           
  p21313      A_19_P00317856   0.993327189    0.000066641   up-up                     Sense               miRNA sequestration
  p36492_v4   A_33_P3221748    0.995546108    0.000029712   up-up                     Sense               
  p19344      A_24_P250535     0.991880869    0.000098613   up-up                                         miRNA sequestration
  p8693       A_24_P250535     0.991653359    0.000104209   up-up                                         miRNA sequestration
  p14566      A_19_P00319254   0.991633933    0.000104694   down-down                 Sense               
  p22664      A_23_P41804      0.995620949    0.000028722   up-up                     Intergenic (10 k)   
  p22663      A_23_P41804      0.997949994    0.000006299   up-up                     Intergenic (10 k)   
  p37916_v4   A_33_P3215277    0.992325400    0.000088123   up-up                                         miRNA sequestration
  p28498      A_33_P3215277    0.993349818    0.000066190   up-up                                         miRNA sequestration
  p20125      A_33_P3256490    0.993114016    0.000070962   up-up                                         miRNA sequestration
  p2107       A_33_P3256490    0.996526411    0.000018078   up-up                                         miRNA sequestration
  p33596      A_23_P347468     0.990934613    0.000122899   down-down                                     miRNA sequestration
  p4313       A_33_P3239084    0.991022154    0.000120541   down-down                                     miRNA sequestration
  p26099      A_23_P381368     0.992698802    0.000079767   down-down                 Intergenic (10 k)   
  p28109      A_23_P381368     0.998436798    0.000003663   down-down                                     miRNA sequestration
  p5755       A_24_P56894      0.990801171    0.000126538   up-up                                         miRNA sequestration
  p16320      A_24_P56894      0.991795931    0.000100684   up-up                                         miRNA sequestration
  p2195       A_23_P134935     0.995584780    0.000029198   up-up                                         miRNA sequestration
  p18273      A_23_P76749      0.991517681    0.000107619   up-up                                         miRNA sequestration
  p18273      A_23_P336929     0.990945545    0.000122604   up-up                                         miRNA sequestration
  p3234       A_24_P380022     −0.990116941   0.000146030   up-down                                       miRNA sequestration
  p16320      A_33_P3319593    −0.991594493   0.000105682   up-down                                       miRNA sequestration
  p37870_v4   A_33_P3319593    −0.993768247   0.000058131   up-down                                       miRNA sequestration
  p36411_v4   A_24_P941217     −0.992930705   0.000074786   down-up                                       miRNA sequestration
  p25274      A_24_P941217     0.993605918    0.000061196   up-up                                         miRNA sequestration
  p30340      A_23_P209320     −0.991624411   0.000104932   down-up                                       miRNA sequestration
  p34907_v4   A_33_P3424297    0.991763098    0.000101490   down-down                                     miRNA sequestration
  p30340      A_33_P3424297    0.990792516    0.000126776   down-down                                     miRNA sequestration
  p8323       A_33_P3418394    0.996071022    0.000023125   up-up                                         miRNA sequestration
  p11437      A_33_P3418394    0.992377207    0.000086939   up-up                                         miRNA sequestration
  p1517       A_21_P0014248    0.993602194    0.000061267   up-up                     Sense               
  p14566      A_19_P00322225   0.991838124    0.000099652   down-down                 Sense               
  p26790      A_24_P940149     0.993717158    0.000059087   down-down                 Antisense           
  p17915      A_23_P416305     −0.993783331   0.000057850   down-up                                       miRNA sequestration
  p750        A_21_P0010797    0.996064600    0.000023201   up-up                     Sense               
  p29253      A_32_P173058     0.992308714    0.000088506   up-up                                         miRNA sequestration
  p36497_v4   A_19_P00319372   0.993618413    0.000060957   up-up                     Intronic            
  p36069_v4   A_19_P00319372   0.994980191    0.000037734   up-up                     Sense               
  p3143       A_23_P383031     0.994487956    0.000045490   down-down                                     miRNA sequestration
  p18271      A_24_P409042     −0.993703568   0.000059343   up-down                                       miRNA sequestration
  p24618      A_24_P409042     0.997488035    0.000009457   down-down                                     miRNA sequestration
  p18273      A_24_P409042     −0.991108770   0.000118230   up-down                                       miRNA sequestration
  p25051      A_24_P409042     −0.994189287   0.000050548   up-down                                       miRNA sequestration
  p18272      A_24_P409042     −0.994084150   0.000052392   up-down                                       miRNA sequestration
  p7539       A_24_P409042     −0.991072129   0.000119205   up-down                                       miRNA sequestration
  p18273      A_23_P397856     −0.993936073   0.000055045   up-down                                       miRNA sequestration
  p6823       A_24_P254346     −0.995095345   0.000036024   up-down                                       miRNA sequestration
  p41766_v4   A_23_P97021      −0.991498540   0.000108105   up-down                                       miRNA sequestration
  p29786      A_23_P97021      −0.995760159   0.000026926   up-down                                       miRNA sequestration
  p9299       A_23_P97021      −0.990583844   0.000132579   up-down                                       miRNA sequestration
  p28283      A_23_P97021      −0.991229915   0.000115034   up-down                                       miRNA sequestration
  p18271      A_24_P373286     0.992099626    0.000093377   up-up                                         miRNA sequestration
  p24976      A_23_P86182      0.994761294    0.000041094   down-down                                     miRNA sequestration
  p16298      A_32_P90080      0.997392142    0.000010193   down-down                                     miRNA sequestration
  p7391       A_23_P371885     0.995164968    0.000035010   up-up                                         miRNA sequestration
  p16320      A_21_P0013080    −0.991724549   0.000102441   up-down                                       miRNA sequestration
  p37870_v4   A_21_P0013080    −0.990354772   0.000139097   up-down                                       miRNA sequestration
  p4547       A_23_P329112     −0.990672972   0.000130084   down-up                                       miRNA sequestration
  p11094      A_23_P26704      −0.990068457   0.000147464   up-down                                       miRNA sequestration
  p8313       A_23_P26704      −0.992380572   0.000086862   up-down                                       miRNA sequestration
  p29606      A_23_P26704      −0.996163250   0.000022053   up-down                                       miRNA sequestration
  p15693      A_23_P304682     −0.990624661   0.000131433   up-down                                       miRNA sequestration
  p12560      A_23_P304682     −0.990915532   0.000123416   up-down                                       miRNA sequestration
  p40979_v4   A_33_P3391005    −0.996196971   0.000021667   down-up                                       miRNA sequestration
  p38890_v4   A_32_P831181     −0.996877479   0.000014610   up-down                                       miRNA sequestration
  p3356       A_21_P0014571    0.991097745    0.000118522   up-up                     Sense               
  p12621      A_19_P00317034   0.993856369    0.000056500   down-down                 Sense               
  p5975       A_23_P63660      −0.991237992   0.000114823   up-down                                       miRNA sequestration
  p9442       A_23_P63660      −0.993997587   0.000053935   up-down                                       miRNA sequestration
  p122        A_21_P0001724    0.990393941    0.000137971   up-up                     Sense               
  p24892      A_23_P211748     0.992553680    0.000082965   up-up                                         miRNA sequestration
  p1517       A_23_P161190     0.990268562    0.000141591   up-up                     Intergenic (10 k)   
  p29965      A_23_P208389     −0.999649344   0.000000184   down-up                                       miRNA sequestration
  p20045      A_23_P208389     −0.993224778   0.000068700   down-up                                       miRNA sequestration
  p33596      A_23_P146209     0.994585549    0.000043895   down-down                                     miRNA sequestration
  p34907_v4   A_33_P3333554    0.992145626    0.000092295   down-down                                     miRNA sequestration
  p38352_v4   A_23_P155666     0.997567735    0.000008867   down-down                                     miRNA sequestration
  p36486_v4   A_23_P64792      −0.992286627   0.000089015   down-up                                       miRNA sequestration
  p23949      A_23_P64792      0.992666927    0.000080464   up-up                                         miRNA sequestration
  p25165      A_23_P50897      0.990700732    0.000129312   down-down                 Antisense           
  p10750      A_33_P3303305    0.991255110    0.000114375   down-down                 Intronic            
  p33919      A_23_P337201     0.997063796    0.000012919   down-down                                     miRNA sequestration
  p1358       A_21_P0010738    0.996673835    0.000016577   down-down                 Sense               
  p6352       A_23_P163306     0.993659613    0.000060173   down-down                                     miRNA sequestration
  p18271      A_24_P109652     0.992664902    0.000080508   up-up                                         miRNA sequestration
  p2107       A_21_P0006705    0.998881367    0.000001876   up-up                     Sense               
  p4653       A_23_P304897     0.995441532    0.000031122   down-down                 Intronic            
  p4963       A_23_P304897     0.999067618    0.000001304   down-down                 Intronic            
  p39057_v4   A_33_P3259542    0.993876252    0.000056136   up-up                                         miRNA sequestration
  p26034      A_33_P3259542    0.990129120    0.000145671   up-up                                         miRNA sequestration
  p6898       A_21_P0014351    0.993996895    0.000053948   down-down                 Sense               
  p34009_v4   A_23_P104188     0.992257395    0.000089690   down-down                 Intergenic (10 k)   
  p34993_v4   A_23_P117582     0.992864673    0.000076188   up-up                                         miRNA sequestration
  p25051      A_23_P117582     0.990949567    0.000122495   up-up                                         miRNA sequestration

DISCUSSION {#s3}
==========

To investigate the role of lncRNAs in the radioresistance of HSCC, we first observed the expression profiles of lncRNA in our established radioresistant HSCC cell model, *i.e*. RS-FaDu. The expression levels of lncRNA in the RS-FaDu and the parental FaDu cells were determined by microarray analysis immediately, at 2 h or 48 h after exposure to 4 Gy irradiation. This approach enabled us to observe the time-course differential expression patterns of lncRNA and mRNA in RS-FaDu *vs*. parental FaDu cells at the early and late stages of their irradiation response. Extracellular stimulation can bring about a rapid change on transcription of related genes. However, it is hard to determine the exact time points of each stage. Borràs-Fresneda, et al. found that a greatly differential transcriptional response in the radioresistant cell line was induced at 4 h after irradiation compared with the radiosensitive one \[[@R27]\]. To make transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiosensitivity, Michna, et al. even detected gene expression at 0.25, 2, 7, 12, 24, 48, 72 and 96 h after irradiation by microarray \[[@R28]\]. According to their experience, we selected these time points to roughly observe the early and late transcriptional response of FaDu and FaDu-RS cells to irradiation in the current study. Additionally, Li et al also carried out research on the relationship between lncRNA and radioresistance in nasopharyngeal carcinoma through genome-wide analyses \[[@R29]\]. However, the authors did not look at response time, which might effectively narrow our search for target lncRNAs and mRNAs.

Furthermore, we identified lncRNAs and mRNAs that were up- or downregulated at above three time points, and they were considered more likely to be involved in HSCC radioresistance. Subsequent validation experiments not only confirmed the reliability of the microarray data but also provided four lncRNA or mRNA candidates for our future mechanism study. Among these, TCONS_00018436 was considered more promising, due to that its potential role was preliminarily verified by its upregulated expression in relapsed tumor samples posterior to radiotherapy and loss-of-function assays.

Considering that altered response processes might occur at different stages after irradiation, we functionally annotated dysregulated mRNAs and performed bioinformatics analyses according to the respective response times. Among the most significantly enriched pathway terms, several attracted our attention because of their close relationship with radioresistance, such as the p53 signaling pathway at 0 h and at 2 h \[[@R30], [@R31]\], and the Wnt signaling pathway at 48 h \[[@R32]\]. These results offer us preferential pathways in which to study the mechanisms underlying HSCC radioresistance. From these results, some candidate mRNAs could be identified based on their altered expression profiles of mRNAs as well.

LncRNAs are well known to affect the expression of target genes in *cis* or in *trans* through binding promoter regions of specific sequences, recruiting relevant transcription factors, and sequestering the interaction of miRNAs with target mRNAs, etc \[[@R33]--[@R36]\]. Thus, we identified dysregulated lncRNAs and their predicted mRNA targets on the basis of complementary base sequences and expression changes from our microarray data. According to dysregulation and association of mRNAs with radioresistance-related pathways in the pathway enrichment analysis, their matched lncRNAs could be found in our prediction results. We thought that it was likely a feasible way to search for lncRNA candidates for the further study.

Emerging evidence indicates that lncRNAs might function as competing endogenous RNAs by sponging miRNAs in a variety of cancers \[[@R37]--[@R40]\]. Notably, the lncRNAs NEAT1 \[[@R25]\] and MALAT1 \[[@R13], [@R24]\] have been shown to modulate radioresistance via sequestration of related miRNAs in nasopharyngeal carcinoma as well as high-risk human papillomavirus-positive cervical cancer. The regulatory roles of miRNAs are well established in the radioresistance of cancers \[[@R41]--[@R45]\], suggesting that we should explore the molecular mechanisms of lncRNAs in HSCC radioresistance from the perspective of lncRNA-miRNA-mRNA axes. Using sequence pairing, a number of dysregulated lncRNAs from our microarray data and matched potential miRNA targets were identified (data not shown) in preparation for verifying our hypothesis.

In addition to the exploration of mechanisms underlying HSCC radioresistance, the identification of biomarkers for predicting radioresistant HSCC is of great clinical significance. Recently, a growing number of circulating or tissue-derived lncRNAs have been shown to be correlated with clinicopathological characteristics in patients with cancer \[[@R46]--[@R48]\], making them promising candidate biomarkers of malignancy. Given the close relationship between lncRNAs and radioresistant HSCC cells discussed above, lncRNAs have the potential to become novel biomarkers for the evaluation of HSCC radioresistance. We further plan to measure the expression levels of candidate lncRNAs in tumor tissues as well as blood samples from HSCC patients and explore the correlation between expression levels and different responses of HSCC patients to routine radiation therapy.

In this study, we for the first time have comprehensively demonstrated the time-course expression profiles of human lncRNAs/mRNAs in radioresistant RS-FaDu cells derived from FaDu cells. Through validation experiments and subsequent preliminary investigation, TCONS_00018436 emerged as a promising candidate for studying the molecular mechanism underlying radioresistance of HSCC. Moreover, a large number of lncRNAs or mRNAs still awaits for being discovered through the bioinformatics analyses. In conclusion, our data laid the foundation for further investigating the roles of these lncRNAs and mRNAs in the occurrence and development of HSCC radioresistance. In addition, novel therapeutic targets and diagnostic biomarkers are likely to be identified in the future on the basis of our data.

MATERIALS AND METHODS {#s4}
=====================

Establishment of a radioresistant cell line {#s4_1}
-------------------------------------------

The HSCC FaDu cell line was purchased from the Type Culture Collection of the Chinese Academy of Sciences (Beijing, China). The cells were cultured in MEM (Gibico, Grand Island, NY, USA) with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 units/ml penicillin, and 100 μg/ml streptomycin and incubated at 37°C with humidified 5% CO~2~.

RS-FaDu cells were created by repeatedly exposing the parental FaDu cells to irradiation \[[@R15]\]. Briefly, FaDu cells were grown in 75-mm^2^ cell culture plates. After the cells reached 70--80% confluence, they were irradiated with X-rays at room temperature. The X-ray generator (MBR-1505R; Hitachi Medical Co., Tokyo, Japan) was operated at 210 kV and 10 mA, with 0.5 mm Al external filtration. The dose rate was 1.8 Gy/min. The cells were exposed to doses of 2, 4, 6, 8, and 10 Gy and were irradiated with each dose twice (total dose of 60 Gy). An interval of 2 to 4 weeks between each dose allowed the surviving cells to regenerate. The process of irradiation and culture lasted for about 10 months. The HSCC cell clones that recovered after exposure to ionizing radiation were collected for further experiments.

Patient specimens {#s4_2}
-----------------

Primary and recurrent tumor samples were obtained from 13 patients who received radiotherapy followed by surgery in Qilu hospital from March 2013 to October 2015, and then salvage surgery due to local recurrence. After surgery, samples were cleaned with phosphate-buffered saline (PBS) and immediately put into liquid nitrogen at once. At least 24 h later, samples were transferred to −80°C for long-term storage. Characteristics of patients were summarized in Table [6](#T6){ref-type="table"}. Prior to this study, written informed contents were signed, and this study was conducted under the approval of the institutional review board of the Ethics Boards of Qilu Hospital.

###### Clinical characteristics of patients

  Characteristics                  No. Patients
  -------------------------------- ---------------------------
  Sex                              
   Female                          0
   Male                            13
  Age (years old)                  (Median 57, Range 49--67)
  Drinking                         
   Regularly                       9
   Occasionally                    4
   Seldom                          0
  Smoking                          
   Regularly                       10
   Occasionally                    0
   Seldom                          3
  \*Histological Differentiation   
   Well-Moderate                   2
   Poor                            11
  \*Clinical Stage                 
   I + II                          1
   III + IV                        12
  \*Treatment                      
   S + X                           13

at the first visit.

S: Surgery; X: radiation.

Clonogenic assay {#s4_3}
----------------

Both parental FaDu and radioresistant RS-FaDu cells were plated in six-well culture plates and irradiated with a single dose of 0, 2, 4, or 6 Gy, respectively. Plated cell numbers were as follows: 300 cells for 0 Gy, 600 cells for 2 Gy, 900 cells for 4 Gy, and 1200 cells for 6 Gy. Following irradiation, the cells were cultured in a 5% CO~2~ atmosphere at 37°C, and the medium was changed every 3 days. After 12 days, colonies were fixed with ethanol for 15 min and stained with 0.1% crystal violet for 15 min. Colonies with \> 50 cells were scored with a ColCount colony counter (Oxford Optronix, Oxford, United Kingdom). All experiments were performed in triplicate. The survival fraction (SF) was estimated by the following formula: SF = \[number of colonies formed/number of cells seeded × plating efficiency of the control group\], where plating efficiency was calculated as the ratio between colonies observed and number of cells plated. Dose-response clonogenic survival curves were plotted on a log-linear scale using Graphpad Prism 5 software.

Apoptosis assay {#s4_4}
---------------

Apoptotic cells were identified by using the Annexin V-FITC and propidium iodide (PI) apoptosis detection kit (BestBio, Shanghai, China) according to the manufacturer\'s instructions. Briefly, RS-FaDu and FaDu cells were seeded at a density of 4 × 10^5^ cells in six-well plates and were incubated for 12 h before being treated with 4 Gy of radiation. The cells were then harvested at four different time points after X-ray exposure (0, 24, 48, and 72 h, respectively). After being washed twice with PBS, the cells were resuspended in 400 μL 1 × binding buffer and stained with 5 μL Annexin V-FITC for 15 min and 10 μL PI for 5 min at 4°C in the dark. Apoptosis was analyzed by a Gallios flow cytometer (Beckman Coulter, Brea, CA, USA). The percentage of total apoptosis was calculated as the sum of the early apoptosis (Annexin V+/PI−) and the late apoptosis (Annexin V+/PI+). The experiments were repeated three times and data were analyzed by Kaluza software (version 1.2; Beckman Coulter).

RNA extraction and microarray analysis {#s4_5}
--------------------------------------

RS-FaDu and FaDu cells were seeded at a density of 4 × 10^5^ cells in three six-well plates each. They were treated with 4 Gy of radiation and then cultured under the indicated experimental conditions. Cells were harvested at three different time points after X-ray exposure (0, 2, and 48 h, respectively). Total RNA from each sample was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer\'s instructions. RNA concentration was quantified by the NanoDrop ND-1000 (NanoDrop Technologies/Thermo Scientific, Wilmington, DE, USA), and RNA integrity was assessed by standard denaturing agarose gel electrophoresis. The sample preparation and microarray hybridization were performed based on the manufacturer\'s standard protocols with minor modifications. Briefly, total RNA was purified after removal of rRNA and tRNA (mRNA-ONLY^™^ Eukaryotic mRNA Isolation Kit, Epicentre, Madison, WI, USA). Then, each sample was amplified and transcribed into fluorescent cRNA, along the entire length of the transcript without 3' bias, utilizing a random priming method. The labeled cRNAs were hybridized onto the Agilent Human LncRNA v4.0 (4 × 180 K, Arraystar; Agilent Technologies, Santa Clara, CA, USA). The slides were then washed, and the tiff-format original array images were acquired by the Agilent G2505C Scanner (Agilent Technologies).

Microarray data analysis {#s4_6}
------------------------

The tiff-format original array images were pre-processed via Agilent Feature Extraction software (version 11.0.1.1) and then quantile normalization and differential expression analysis were conducted using the GeneSpring GX software package (version 11.5.1; Agilent Technologies). Cluster analysis and graphical illustration were performed using Cluster 3.0 software. Time-course differentially expressed lncRNAs and mRNAs with statistical significance between the two groups were identified through scatter plot filtering and volcano plot filtering. To filter out outlier samples, we performed hierarchical clustering to show any differences in expression intensity between the clustering group and true group results. The differentially expressed mRNAs were submitted to six pathway databases (KEGG PATHWAY, PID Curated, PID BioCarta, PID Reactome, BioCyc, Reactome, and Panther) for pathway enrichment analysis. After lncRNA and mRNA correlation, lncRNA target prediction included cis-prediction and trans-prediction. To determine cis-prediction, we searched for mRNAs that were in the region of 10 kb around the lncRNA. Trans-prediction was based on sequence alignment, which aligns lncRNA to the 3′UTR of mRNA. Then lncRNA-mRNA pairs that share similar sequences were identified from the trans-prediction results. In the lncRNA target prediction analysis, mRNA targets were predicted from cis-prediction and trans-prediction.

Validation of lncRNA and mRNA expression by quantitative real-time polymerase chain reaction {#s4_7}
--------------------------------------------------------------------------------------------

Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate the microarray data. Briefly, total RNA was reverse-transcribed to cDNA using SuperScript^™^ III Reverse Transcriptase (Invitrogen) following the manufacturer\'s protocol. qRT-PCR was performed using the SYBR Green chemistry in the GeneAmp PCR System 9700 (ABI Applied Biosystems, Foster City, CA, USA). The forward and reverse primers for validation are listed in Table [7](#T7){ref-type="table"}. PCR was performed in a 10-μL reaction volume and consisted of an initial denaturation step at 95°C for 10 min followed by amplification with 40 cycles at 95°C for 10 sec and 60°C for 60 sec. The threshold cycle (CT) was defined as the cycle number at which the fluorescence passed a predetermined threshold. Both target and reference (β-actin) genes were amplified in separate wells in triplicate. Gene expression was calculated using the comparative threshold cycle (2^−ΔCT^) method.

###### Primers used for qRT-PCR

  mRNAs/lncRNAs     Forward primers (5′--3′)   Reverse primers (5′--3′)   bp
  ----------------- -------------------------- -------------------------- -----
  ENST00000470135   TTGCCAGCAATTCATCAGAG       GGGATATGCCAACCTTGAGA       151
  TCONS_00010875    TCGTTCACACACCCACTCAT       CGAGTGGGCAAGTTAGTGTG       153
  TCONS_00018436    CCACCTCAGGATGGAAATGT       TCCCCAACCAAAGTCTTGTC       160
  hox-HOXD10-35     GCTCCTTCACCACCAACATT       AAATATCCAGGGACGGGAAC       154
  CKMT1A            ACCTGACCCCAGCAGTCTAT       AACACGTTCCACCTCTCGTC       374
  GPNMB             AAGATTGCCACTTGATGCCG       TCCCTCATGTAAGCAGAAGGTC     75
  FBLN5             CTCACTGTTACCATTCTGGCTC     GACTGGCGATCCAGGTCAAAG      89
  GDA               GCTGGAAGTAGCATAGACCTGC     TCTTCTGCAAAGTCGATGTTCTG    95
  ACTB              GTGGCCGAGGACTTTGATTG       CCTGTAACAACGCATCTCATATT    73

Lentiviral transfection assay {#s4_8}
-----------------------------

Lentivirus containing short hairpin RNA (shRNA) of TCONS_00018436 or empty vectors used as control were purchased from GeneChem (Shanghai, China). And the lentiviral transfection assays were performed following manufacture\'s instructions. Stably transfected cells were screened by Puromycin (3 mg/mL) purchased from Sigma.

Statistical analysis {#s4_9}
--------------------

Data were presented as mean ± standard deviation (SD) and statistical differences between two experimental groups were determined by using paired *t*-test or Student\'s *t*-test on SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Statistical differences in the microarray results were analyzed by fold change (FC) and *P*-value, and the FC and *P*-value were calculated based on normalized data. FC was calculated by computing the ratio of mean intensity of the case group to that of the control group, while *P*-value was calculated using Student\'s *t*-test. The thresholds for differentially expressed genes were set at FC ≥ 2.0 and *P*-value \< 0.05. For the lncRNA and mRNA correlation analysis, the Pearson correlation coefficient was calculated to show the correlation between lncRNA and mRNA expression and *P*-value was calculated to show the significance of the Pearson correlation coefficient. Correlation \> 0.99 or correlation \< −0.99, and *P*-value \< 0.05 were adopted to filter out random relationship. In all analyses, a two-sided *P*-value \< 0.05 was considered statistically significant.
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